TYR and melanoma: On the other hand, geoditin A at sublethal doses (≤5.0 μg·mL−1) decreased melanogenesis and glycosylation of tyrosinase (TYR) in murine B16F10 melanoma cells (CRL6475, ATCC) in a dose-dependent manner, but ROS- and MITF- in an independent one.